2.21
Schlusskurs vom Vortag:
$2.19
Offen:
$2.19
24-Stunden-Volumen:
65,139
Relative Volume:
0.05
Marktkapitalisierung:
$19.84M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.8403
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
-6.75%
1M Leistung:
+1.84%
6M Leistung:
+59.57%
1J Leistung:
-14.87%
Aytu Biopharma Inc Stock (AYTU) Company Profile
Firmenname
Aytu Biopharma Inc
Sektor
Telefon
(720) 437-6580
Adresse
7900 E. UNION AVENUE, DENVER
Vergleichen Sie AYTU mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AYTU
Aytu Biopharma Inc
|
2.21 | 19.66M | 93.76M | -13.68M | 8.77M | -2.63 |
![]()
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-01 | Eingeleitet | Lake Street | Buy |
2025-06-30 | Eingeleitet | Ascendiant Capital Markets | Buy |
2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-05-29 | Eingeleitet | H.C. Wainwright | Buy |
Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Path To Profitability - Yahoo Finance
Will Aytu BioPharma Inc. see short term momentum2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
What the charts say about Aytu BioPharma Inc. todayMarket Activity Summary & Daily Momentum Trading Reports - Newser
Detecting support and resistance levels for Aytu BioPharma Inc.2025 Risk Factors & Fast Gain Stock Tips - Newser
How to recover losses in Aytu BioPharma Inc. stockTrade Risk Summary & Risk Controlled Stock Pick Alerts - Newser
How hedge fund analytics apply to Aytu BioPharma Inc. stockPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
Combining price and volume data for Aytu BioPharma Inc.Earnings Overview Summary & Real-Time Chart Pattern Alerts - Newser
Can trapped investors hope for a rebound in Aytu BioPharma Inc.Portfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Aytu BioPharma Inc. stock daily chart insightsEarnings Overview Summary & Fast Exit and Entry Trade Guides - Newser
Will Aytu BioPharma Inc. stock recover after recent dropPortfolio Value Summary & Consistent Income Trade Recommendations - Newser
Live market analysis of Aytu BioPharma Inc.July 2025 Action & AI Enhanced Trading Signals - Newser
Using Python tools to backtest Aytu BioPharma Inc. strategies2025 Top Gainers & Smart Investment Allocation Tips - Newser
Will Aytu BioPharma Inc. outperform the market2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
What recovery options are there for Aytu BioPharma Inc.July 2025 Short Interest & Risk Controlled Daily Plans - Newser
What machine learning models say about Aytu BioPharma Inc.2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Why Aytu BioPharma Inc. stock attracts strong analyst attentionTrade Analysis Report & Fast Moving Stock Trade Plans - Newser
Multi asset correlation models including Aytu BioPharma Inc.Rate Cut & Low Risk Investment Opportunities - Newser
Full technical analysis of Aytu BioPharma Inc. stockMarket Growth Review & Pattern Based Trade Signal System - Newser
Can Aytu BioPharma Inc. benefit from deglobalizationFast ROI Stock Opportunities - thegnnews.com
Risk adjusted return profile for Aytu BioPharma Inc. analyzedFundamental Analysis for Value Stock Selection - Newser
Aytu BioPharma Inc. stock retracement – recovery analysisMarket Opportunity Tracker for Swing Traders - Newser
What makes Aytu BioPharma Inc. stock price move sharplyCapitalize on market shifts with expert advice - Jammu Links News
Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aytu Biopharma Inc-Aktie (AYTU) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):